Overview
MenACWY is a meningococcal conjugate vaccine that protects against four major serogroups of Neisseria meningitidis:
- Serogroup A
- Serogroup C
- Serogroup W
- Serogroup Y
It is used to prevent invasive meningococcal disease, including meningitis and meningococcemia.
Type of Vaccine
- Conjugate vaccine.
- Contains purified capsular polysaccharides from the four serogroups.
- Polysaccharides are chemically linked to a protein carrier.
The conjugation improves immune response, especially in children, by inducing T-cell dependent immunity and immunological memory.
Mechanism of Action
- Stimulates production of specific antibodies against capsular polysaccharides.
- Prevents bacterial colonisation and invasion.
- Reduces carriage and transmission in vaccinated populations.
Indications
Recommended for:
- Adolescents and young adults.
- Individuals living in crowded settings such as hostels or military barracks.
- Travellers to regions with high meningococcal prevalence, especially sub-Saharan Africa.
- Individuals with certain medical conditions such as complement deficiency or asplenia.
In some countries, vaccination is mandatory for pilgrims travelling for Hajj.
Dosage Schedule
- Typically administered as a single intramuscular dose.
- Booster doses may be required depending on age at first vaccination and risk profile.
National schedules vary by country.
Efficacy
- Highly effective in preventing disease caused by serogroups A, C, W and Y.
- Contributes to herd immunity by reducing nasopharyngeal carriage.
- Does not protect against serogroup B, which requires a separate vaccine.
Safety Profile
- Generally well tolerated.
- Common mild side effects include pain at injection site, mild fever and fatigue.
- Serious adverse events are rare.
Public Health Importance
- Prevents outbreaks in high-risk populations.
- Reduces morbidity and mortality associated with meningococcal disease.
- Important tool in epidemic control strategies.
The MenACWY vaccine plays a critical role in preventing invasive meningococcal infections and is an essential component of adolescent and high-risk group immunisation programmes worldwide.
